glp 1 ra with cvd benefit The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management | Current Cardiovascular Risk Reports GLP-1 and GIP–GLP-1 therapies benefits

126 NagoshiN.TsujiO.KitamuraK.SudaK.MaedaT.YatoY.et al (2020)

Hypersensitivity reactions Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with semaglutide Avoid use in patients with known hypersensitivity to semaglutide and use caution in patients with a history of reactions to other GLP-1 analogs Semaglutide antibodies Semaglutide can induce an immune response that leads to the production of anti-semaglutide antibodies, and in some cases, these antibodies cross-react with endogenous GLP-1 In trials, 2.9% of Wegovy-treated patients developed anti-semaglutide antibodies, and of these patients, 56% had antibodies that cross-reacted with endogenous GLP-1

Temperature stability matters during transport

Clinical Context: Why Prescribers Consider Ipamorelin in Liver Disease Sarcopenia affects 40 to 70% of patients with cirrhosis and independently predicts mortality, transplant waitlist dropout, and post-transplant complications

Furthermore, the low hypoglycaemia risk associated with this combination enhances treatment safety and patient quality of life, avoiding the glucose fluctuations and weight gain often seen with insulin intensification

If there is kidney obstruction, permanent kidney damage can occur if left untreated